VF
LPCN icon

Virtu Financial’s Lipocine LPCN Stock Holding History

Virtu Financial’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,205
Closed -$7K – 1803
2023
Q1 		$7K Buy
+1,205
New +$9.31K ﹤0.01% 1374
2022
Q4 		– Sell
-5,495
Closed -$42K – 1925
2022
Q3 		$42K Buy
+5,495
New +$61.4K ﹤0.01% 1239
2022
Q2 		– Sell
-7,326
Closed -$171K – 1850
2022
Q1 		$171K Buy
7,326
+415
+6% +$8.68K 0.01% 836
2021
Q4 		$116K Buy
6,911
+5,142
+291% +$95.5K 0.01% 1068
2021
Q3 		$33K Buy
+1,769
New +$39K ﹤0.01% 1333
2021
Q2 		– Sell
-11,258
Closed -$289K – 1817
2021
Q1 		$289K Sell
11,258
-977
-8% -$28.2K 0.02% 833
2020
Q4 		$283K Buy
+12,235
New +$294K 0.03% 668
2019
Q4 		$4K Buy
+631
New +$16.2K ﹤0.01% 1392
2018
Q4 		– Sell
-1,211
Closed -$28K – 1805
2018
Q3 		$28K Sell
1,211
-295
-20% -$7.25K ﹤0.01% 1373
2018
Q2 		$33K Buy
+1,506
New +$35.9K ﹤0.01% 1817
2017
Q4 		– Sell
-934
Closed -$63K – 2720
2017
Q3 		$63K Buy
+934
New +$67.5K ﹤0.01% 2187

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial's LPCN Position: Q2 2023 in Review

Virtu Financial sold out of Lipocine (LPCN) in Q2 2023, closing a stake of 1,205 shares — an estimated $7K sold.

Virtu Financial first reported a position in LPCN in Q3 2017 and held it in 11 quarters. The position peaked at $289K in Q1 2021. 24 funds tracked by Wall St. Rank hold LPCN as of Q2 2023.

  • Virtu Financial reported no remaining Lipocine position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 1,205 Lipocine shares in Q2 2023, an estimated $7K.
  • Virtu Financial first reported a position in Lipocine in Q3 2017 and held it in 11 quarters.
  • Virtu Financial's Lipocine position peaked at $289K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Lipocine as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.